KLRK1 and prostate cancer: Dhar, et al., showed that membrane-bound MIC activated NKG2D to potentiate anti-tumor NK cell responses in the TRAMP/MIC model of prostate cancer, however sMIC activated signalosome activity in NK cells leading to NK cell suppression [139].